425 related articles for article (PubMed ID: 32981510)
1. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.
Mihăilă RG
Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True.
D'Agostino M; Innorcia S; Boccadoro M; Bringhen S
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33139668
[TBL] [Abstract][Full Text] [Related]
3. Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells.
Dabkowska A; Domka K; Firczuk M
Front Immunol; 2024; 15():1363102. PubMed ID: 38638442
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral bispecific ligand-antibody conjugate increases survival of animals bearing endogenously arising brain tumors.
Patrick TA; Kranz DM; Zachary JF; Roy EJ
Int J Cancer; 1998 Nov; 78(4):470-9. PubMed ID: 9797136
[TBL] [Abstract][Full Text] [Related]
5. [Cancer therapy using bispecific antibodies].
Kadowaki N
Rinsho Ketsueki; 2018; 59(10):1942-1947. PubMed ID: 30305495
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD30 in anaplastic large cell lymphoma.
Vadakara J; Pro B
Curr Hematol Malig Rep; 2012 Dec; 7(4):285-91. PubMed ID: 23065407
[TBL] [Abstract][Full Text] [Related]
7. Future of monoclonal antibodies in the treatment of hematologic malignancies.
Reff ME; Hariharan K; Braslawsky G
Cancer Control; 2002; 9(2):152-66. PubMed ID: 11965235
[TBL] [Abstract][Full Text] [Related]
8. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.
Shah N; Chari A; Scott E; Mezzi K; Usmani SZ
Leukemia; 2020 Apr; 34(4):985-1005. PubMed ID: 32055000
[TBL] [Abstract][Full Text] [Related]
9. Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.
Derby L; Czuczman MS
Future Oncol; 2011 Aug; 7(8):963-79. PubMed ID: 21823892
[TBL] [Abstract][Full Text] [Related]
10. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia.
Liu D; Zhao J; Song Y; Luo X; Yang T
J Hematol Oncol; 2019 Feb; 12(1):15. PubMed ID: 30736842
[TBL] [Abstract][Full Text] [Related]
12. [ALL in adult patients: Contribution and limits of pediatric management].
Rabian F; Boissel N
Bull Cancer; 2021 Feb; 108(2):187-197. PubMed ID: 32981690
[TBL] [Abstract][Full Text] [Related]
13. Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations.
Shim H
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111076
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in hematologic malignancies: past, present, and future.
Im A; Pavletic SZ
J Hematol Oncol; 2017 Apr; 10(1):94. PubMed ID: 28434396
[TBL] [Abstract][Full Text] [Related]
15. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
Cho SF; Anderson KC; Tai YT
Front Immunol; 2018; 9():1821. PubMed ID: 30147690
[TBL] [Abstract][Full Text] [Related]
16. Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
Demichelis-Gómez R; Pérez-Sámano D; Bourlon C
Curr Oncol Rep; 2019 Feb; 21(2):17. PubMed ID: 30715609
[TBL] [Abstract][Full Text] [Related]
17. Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
Epner EM; Saroya BS; Hasanali ZS; Loughran TP
Exp Hematol; 2016 Mar; 44(3):157-60. PubMed ID: 26802532
[TBL] [Abstract][Full Text] [Related]
18. Bringing Together the Power of T Cell Receptor Mimic and Bispecific Antibodies for Cancer Immunotherapy: Still a Long Way to Go.
Shivarov V; Blazhev G
Monoclon Antib Immunodiagn Immunother; 2021 Apr; 40(2):81-85. PubMed ID: 33900820
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
Sikaria S; Aldoss I; Akhtari M
Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
[TBL] [Abstract][Full Text] [Related]
20. Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era.
Klener P; Etrych T; Klener P
Curr Med Chem; 2019; 26(6):1002-1018. PubMed ID: 28990505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
